WHO: Two new candidate vaccines join Ebola trial
WHO recommends adding two new Ebola candidate vaccines—ChAdOx1, developed by Oxford University in collaboration with Serum Institute of India, and Moderna's mRNA-1469—to the ongoing TUMAINI clinical t
VolFlash analysisNot analysed
This event fell outside the real-time analysis window (published more than 6 hours ago), so no analysis was generated. Live events are analysed within a minute of publication.
Related guidesHow markets transmit
One email a day — don't miss the big ones
The 8 highest-severity events of the past 24h, with our read and source links. Unsubscribe anytime.
Published：2026-11-04 16:11:14 · Source：wallstcn · Automatically aggregated and analysed — verify against the original source.